These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 17218947)

  • 21. Effective tumor targeted gene transfer using PEGylated adenovirus vector via systemic administration.
    Gao JQ; Eto Y; Yoshioka Y; Sekiguchi F; Kurachi S; Morishige T; Yao X; Watanabe H; Asavatanabodee R; Sakurai F; Mizuguchi H; Okada Y; Mukai Y; Tsutsumi Y; Mayumi T; Okada N; Nakagawa S
    J Control Release; 2007 Sep; 122(1):102-10. PubMed ID: 17628160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Type I IFN innate immune response to adenovirus-mediated IFN-gamma gene transfer contributes to the regression of cutaneous lymphomas.
    Urosevic M; Fujii K; Calmels B; Laine E; Kobert N; Acres B; Dummer R
    J Clin Invest; 2007 Oct; 117(10):2834-46. PubMed ID: 17823660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic damage of tumor vessels with ultra low-dose endothelial-monocyte activating polypeptide-II and neovasculature-targeted tumor necrosis factor-alpha.
    Crippa L; Gasparri A; Sacchi A; Ferrero E; Curnis F; Corti A
    Cancer Res; 2008 Feb; 68(4):1154-61. PubMed ID: 18281491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Construction of recombinant adenovirus vector carrying human TIMP-1 cDNA and its expression in vitro].
    Xia D; Yan L; Xu L; Tong Y; Zuo H; Zhao L
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Apr; 24(2):420-4. PubMed ID: 17591273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combining tumor-targeted superantigens with interferon-alpha results in synergistic anti-tumor effects.
    Sundstedt A; Celander M; Hedlund G
    Int Immunopharmacol; 2008 Mar; 8(3):442-52. PubMed ID: 18279798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of adenovirus-mediated TK/GCV gene therapy in combination with TNF-alpha against murine bladder cancer cells in vitro].
    Shi XH; Tan WL; Zhu WH; Liang ZK; DU YJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):750-3. PubMed ID: 18504196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complete regression of advanced primary and metastatic mouse melanomas following combination chemoimmunotherapy.
    Kohlmeyer J; Cron M; Landsberg J; Bald T; Renn M; Mikus S; Bondong S; Wikasari D; Gaffal E; Hartmann G; Tüting T
    Cancer Res; 2009 Aug; 69(15):6265-74. PubMed ID: 19622767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenovirus carrying TIMP-3: a potential tool for cervical cancer treatment.
    Zhang Y; Qian H; Lin C; Lang J; Xiang Y; Fu M; Zhang X; Liang X
    Gynecol Oncol; 2008 Jan; 108(1):234-40. PubMed ID: 17976707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concomitant use of Ad5/35 chimeric oncolytic adenovirus with TRAIL gene and taxol produces synergistic cytotoxicity in gastric cancer cells.
    Chen L; Chen D; Gong M; Na M; Li L; Wu H; Jiang L; Qian Y; Fang G; Xue X
    Cancer Lett; 2009 Nov; 284(2):141-8. PubMed ID: 19447545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The enhanced anti-angiogenic and antitumor effects of combining flk1-based DNA vaccine and IP-10.
    Lu XL; Jiang XB; Liu RE; Zhang SM
    Vaccine; 2008 Oct; 26(42):5352-7. PubMed ID: 18723067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenovirus-mediated interleukin-13 gene therapy attenuates acute kidney allograft injury.
    Sandovici M; Deelman LE; van Goor H; Helfrich W; de Zeeuw D; Henning RH
    J Gene Med; 2007 Dec; 9(12):1024-32. PubMed ID: 17902182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
    Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor-localized ligation of CD3 and CD28 with systemic regulatory T-cell depletion induces potent innate and adaptive antitumor responses.
    Lee CH; Chiang YH; Chang SE; Chong CL; Cheng BM; Roffler SR
    Clin Cancer Res; 2009 Apr; 15(8):2756-66. PubMed ID: 19318495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beneficial effects of treatment with transglutaminase inhibitor cystamine on macrophage response in NZB/W F1 mice.
    Hsu TC; Chiang SY; Huang CY; Tsay GJ; Yang CW; Huang CN; Tzang BS
    Exp Biol Med (Maywood); 2007 Feb; 232(2):195-203. PubMed ID: 17259326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-based gene therapy modifies matrix remodeling after a myocardial infarction in tissue inhibitor of matrix metalloproteinase-3-deficient mice.
    Angoulvant D; Fazel S; Weisel RD; Lai TY; Fedak PW; Chen L; Rafati S; Seneviratne CK; Degousee N; Li RK
    J Thorac Cardiovasc Surg; 2009 Feb; 137(2):471-80. PubMed ID: 19185172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and canstatin gene suppression therapy on breast tumor xenograft growth in mice.
    Wang WB; Zhou YL; Heng DF; Miao CH; Cao YL
    Breast Cancer Res Treat; 2008 Jul; 110(2):283-95. PubMed ID: 17899369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
    Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
    Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose chemotherapy augments the efficacy of recombinant adenovirus vaccines and improves the therapeutic outcome.
    Grinshtein N; Ventresca M; Margl R; Bernard D; Yang TC; Millar JB; Hummel J; Beermann F; Wan Y; Bramson JL
    Cancer Gene Ther; 2009 Apr; 16(4):338-50. PubMed ID: 18989352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potent antitumor effect of TRAIL mediated by a novel adeno-associated viral vector targeting to telomerase activity for human hepatocellular carcinoma.
    Wang Y; Huang F; Cai H; Zhong S; Liu X; Tan WS
    J Gene Med; 2008 May; 10(5):518-26. PubMed ID: 18338833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiation enhances adenoviral gene therapy in pancreatic cancer via activation of cytomegalovirus promoter and increased adenovirus uptake.
    Egami T; Ohuchida K; Mizumoto K; Onimaru M; Toma H; Nishio S; Nagai E; Matsumoto K; Nakamura T; Tanaka M
    Clin Cancer Res; 2008 Mar; 14(6):1859-67. PubMed ID: 18347189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.